Insider Trading Alert - CRM, LPNT, SPLK, DGI And AME Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Nov. 1, 2013, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $2,920.00 to $142,506,400.00.

Highlighted Stocks Traded by Insiders:

Salesforce.com (CRM) - FREE Research Report

Conway Craig who is Director at Salesforce.com sold 1,600 shares at $53.56 on Nov. 1, 2013. Following this transaction, the Director owned 15,856 shares meaning that the stake was reduced by 9.17% with the 1,600 share transaction.

The shares most recently traded at $55.31, up $1.75, or 3.16% since the insider transaction. Historical insider transactions for Salesforce.com go as follows:

  • 4-Week # shares sold: 13,600
  • 12-Week # shares sold: 49,076
  • 24-Week # shares sold: 57,076

The average volume for Salesforce.com has been 4.9 million shares per day over the past 30 days. Shares are up 26.97% year to date as of the close of trading on Friday.

salesforce.com, inc. provides enterprise cloud computing solutions to various businesses and industries worldwide. Currently there are 23 analysts that rate Salesforce.com a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CRM - FREE

TheStreet Quant Ratings rates Salesforce.com as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Salesforce.com Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

LifePoint Hospitals (LPNT) - FREE Research Report

Coggin Michael S. who is SVP & Chief Acctg. Officer at LifePoint Hospitals sold 2,000 shares at $51.14 on Nov. 1, 2013. Following this transaction, the SVP & Chief Acctg. Officer owned 10,435 shares meaning that the stake was reduced by 16.08% with the 2,000 share transaction.

The shares most recently traded at $51.99, up $0.85, or 1.63% since the insider transaction. Historical insider transactions for LifePoint Hospitals go as follows:

  • 24-Week # shares sold: 6,727

The average volume for LifePoint Hospitals has been 318,100 shares per day over the past 30 days. LifePoint Hospitals has a market cap of $2.4 billion and is part of the health care sector and health services industry. Shares are up 36.79% year to date as of the close of trading on Friday.

LifePoint Hospitals, Inc., through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States. The company has a P/E ratio of 19.2. Currently there are 2 analysts that rate LifePoint Hospitals a buy, 2 analysts rate it a sell, and 11 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LPNT - FREE

TheStreet Quant Ratings rates LifePoint Hospitals as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full LifePoint Hospitals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Splunk (SPLK) - FREE Research Report

Neustaetter Thomas M who is Director at Splunk sold 1,500 shares at $62.67 on Nov. 1, 2013. Following this transaction, the Director owned 89,603 shares meaning that the stake was reduced by 1.65% with the 1,500 share transaction.

The shares most recently traded at $63.02, up $0.35, or 0.55% since the insider transaction. Historical insider transactions for Splunk go as follows:

  • 4-Week # shares sold: 4,500
  • 12-Week # shares sold: 253,613
  • 24-Week # shares sold: 370,524

The average volume for Splunk has been 1.1 million shares per day over the past 30 days. Splunk has a market cap of $6.6 billion and is part of the technology sector and computer software & services industry. Shares are up 116.09% year to date as of the close of trading on Friday.

Splunk, Inc. provides software solutions that provide real-time operational intelligence. Currently there are 9 analysts that rate Splunk a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPLK - FREE

TheStreet Quant Ratings rates Splunk as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. Get the full Splunk Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

DigitalGlobe (DGI) - FREE Research Report

Scott Walter S. who is EVP & Chief Technical Officer at DigitalGlobe sold 170 shares at $32.70 on Nov. 1, 2013. Following this transaction, the EVP & Chief Technical Officer owned 151,886 shares meaning that the stake was reduced by 0.11% with the 170 share transaction.

The shares most recently traded at $34.59, up $1.89, or 5.46% since the insider transaction. Historical insider transactions for DigitalGlobe go as follows:

  • 12-Week # shares sold: 19,717
  • 24-Week # shares sold: 22,177

The average volume for DigitalGlobe has been 782,800 shares per day over the past 30 days. DigitalGlobe has a market cap of $2.4 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 30.2% year to date as of the close of trading on Friday.

DigitalGlobe, Inc. provides commercial earth imagery products and services in the Americas and internationally. The company operates in two segments, Defense and Intelligence, and Commercial. Currently there are 4 analysts that rate DigitalGlobe a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DGI - FREE

TheStreet Quant Ratings rates DigitalGlobe as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full DigitalGlobe Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Ametek (AME) - FREE Research Report

Varet Elizebeth R who is Director at Ametek sold 1,000 shares at $47.83 on Nov. 1, 2013. Following this transaction, the Director owned 125,490 shares meaning that the stake was reduced by 0.79% with the 1,000 share transaction.

The shares most recently traded at $48.05, up $0.22, or 0.47% since the insider transaction. Historical insider transactions for Ametek go as follows:

  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 20,000

The average volume for Ametek has been 1.8 million shares per day over the past 30 days. Ametek has a market cap of $11.7 billion and is part of the industrial goods sector and industrial industry. Shares are up 27.31% year to date as of the close of trading on Friday.

AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America. The company operates in two segments, Electronic Instruments Group and Electromechanical Group. The stock currently has a dividend yield of 0.5%. The company has a P/E ratio of 23.6. Currently there are 5 analysts that rate Ametek a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AME - FREE

TheStreet Quant Ratings rates Ametek as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Ametek Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Dow Futures Turn Positive After Boeing Earnings Blowout; Twitter Boosts Nasdaq

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook's Investors Have a Big Day Ahead

Facebook's Investors Have a Big Day Ahead

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World